Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Interest Expenses (2016 - 2025)

iBio (IBIO) has disclosed Interest Expenses for 16 consecutive years, with $41000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 28.07% to $41000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $175000.0, a 22.57% decrease, with the full-year FY2025 number at $212000.0, up 23.26% from a year prior.
  • Interest Expenses was $41000.0 for Q4 2025 at iBio, up from $36000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $608000.0 in Q3 2021 to a low of $26000.0 in Q3 2023.
  • A 5-year average of $87307.7 and a median of $44000.0 in 2025 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: soared 119.23% in 2024, then tumbled 36.84% in 2025.
  • iBio's Interest Expenses stood at $608000.0 in 2021, then crashed by 94.9% to $31000.0 in 2022, then increased by 9.68% to $34000.0 in 2023, then skyrocketed by 67.65% to $57000.0 in 2024, then dropped by 28.07% to $41000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Interest Expenses are $41000.0 (Q4 2025), $36000.0 (Q3 2025), and $44000.0 (Q2 2025).